These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2242080)

  • 1. [Transdermal administration of insulin in type II diabetics. Results of a clinical pilot study].
    Liedtke RK; Sorger M; Merk F; Vetter H
    Arzneimittelforschung; 1990 Aug; 40(8):884-6. PubMed ID: 2242080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
    Ledermann H; Höxter G
    Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled insulin as adjunctive therapy in subjects with type 2 diabetes failing oral agents: a controlled proof-of-concept study.
    Hausmann M; Dellweg S; Osborn C; Heinemann L; Buchwald A; Rosskamp R; Genova P; Heise T
    Diabetes Obes Metab; 2006 Sep; 8(5):574-80. PubMed ID: 16918593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
    Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
    Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of glibenclamide in insulin-treated diabetic patients with a residual insulin secretion.
    Mauerhoff T; Ketelslegers JM; Lambert AE
    Diabete Metab; 1986 Feb; 12(1):34-8. PubMed ID: 3084315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination treatment with insulin and sulfonylurea. Results of a 5-year study].
    Holländer E
    Z Gesamte Inn Med; 1989 May; 44(9):261-4. PubMed ID: 2662659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin versus glipizide treatment in patients with non-insulin-dependent diabetes mellitus. Effects on blood pressure and glucose tolerance.
    Levy J; Vandenberg M; Grunberger G
    Am J Hypertens; 1995 May; 8(5 Pt 1):445-53. PubMed ID: 7662219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of insulin glargine and glimepiride in controlling blood glucose of ethnic Japanese patients with type 2 diabetes mellitus.
    Kawamori R; Eliaschewitz FG; Takayama H; Hayashida CY
    Diabetes Res Clin Pract; 2008 Jan; 79(1):97-102. PubMed ID: 17919763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
    van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
    Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination treatment of insulin dependent elderly diabetics (type II diabetes) with the sulfonylurea compound glibenclamide].
    Naurath HJ; Füsgen I
    Z Gerontol; 1985; 18(5):302-4. PubMed ID: 3934860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Palatinite in type II diabetics. Effect on blood-glucose, serum-insulin, C-peptide and free fatty acids].
    Petzoldt R; Lauer P; Spengler M; Schöffling K
    Dtsch Med Wochenschr; 1982 Dec; 107(50):1910-3. PubMed ID: 6754331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effectiveness of combined insulin and sulfonylurea in treating non-insulin dependent diabetic patients].
    Sun Y; Xiong Y; Yang J
    Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):246-9. PubMed ID: 7587604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics.
    Ponchner M; Taylor R; Heine R; Alberti KG
    Horm Metab Res; 1984 Apr; 16(4):208. PubMed ID: 6373546
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood glucose and free insulin levels after the administration of insulin by conventional syringe or jet injector in insulin treated type 2 diabetics.
    Kerum G; Profozić V; Granić M; Skrabalo Z
    Horm Metab Res; 1987 Sep; 19(9):422-5. PubMed ID: 3319860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The artificial endocrine pancreas in clinical medicine and in research].
    Pfeiffer EF; Beischer W; Thum C; Clemens AH
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():279-96. PubMed ID: 796524
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined insulin and sulfonylurea therapy in non-insulin-dependent diabetics with secondary failure to oral drugs: a one year follow-up.
    Quatraro A; Consoli G; Ceriello A; Giugliano D
    Diabete Metab; 1986 Dec; 12(6):315-8. PubMed ID: 3545931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of preoral and transdermal insulin preparations on blood glucose concentration in mice].
    Liedtke RK; Suwelack K; Karzel K
    Arzneimittelforschung; 1990 Aug; 40(8):880-3. PubMed ID: 2242079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.